{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:01:59Z","timestamp":1790499719483,"version":"4.1.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Cystic fibrosis (CF) airway disease is characterized by excessive and accumulative mucus in the airways. Mucociliary clearance becomes defective as mucus secretions become hyperconcentrated and viscosity increases. The CFTR-knockout (KO) rat has been previously shown to progressively develop delayed mucociliary transport, secondary to increased viscoelasticity of airway secretions. The humanized-G551D CFTR rat model has demonstrated that abnormal mucociliary clearance and hyperviscosity is reversed by ivacaftor treatment. In this study, we sought to identify the components of mucus that changes as the rat ages to contribute to these abnormalities. We found that Muc5b concentrations, and to a lesser extent Muc5ac, in the airway were increased in the KO rat compared to WT, and that Muc5b concentration was directly related to the viscosity of the mucus. Additionally, we found that methacholine administration to the airway exacerbates these characteristics of disease in the KO, but not WT rat trachea. Lastly we determined that at 6\u00a0months of age, CF rats had mucus that was adherent to the airway epithelium, a process that is reversed by ivacaftor therapy in the hG551D rat. Overall, these data indicate that accumulation of Muc5b initiates the muco-obstructive process in the CF lung prior to infection.<\/jats:p>","DOI":"10.3389\/fphys.2022.884166","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T07:48:16Z","timestamp":1651132096000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Muc5b Contributes to Mucus Abnormality in Rat Models of Cystic Fibrosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Johnathan D.","family":"Keith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney M.","family":"Fernandez-Petty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley M.","family":"Oden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Birket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e89752","DOI":"10.1172\/jci.insight.89752","article-title":"Defective Postsecretory Maturation of MUC5B Mucin in Cystic Fibrosis Airways","volume":"2","author":"Abdullah","year":"2017","journal-title":"JCI Insight"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/nejmoa0909825","article-title":"Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e97199","DOI":"10.1172\/jci.insight.97199","article-title":"Development of an Airway Mucus Defect in the Cystic Fibrosis Rat","volume":"3","author":"Birket","year":"2018","journal-title":"JCI Insight"},{"key":"B4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1164\/rccm.201404-0670oc","article-title":"A Functional Anatomic Defect of the Cystic Fibrosis Airway","volume":"190","author":"Birket","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1164\/rccm.202002-0369oc","article-title":"Ivacaftor Reverses Airway Mucus Abnormalities in a Rat Model Harboring a Humanized G551D-CFTR","volume":"202","author":"Birket","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/thx.2006.062190","article-title":"A Morphometric Study of Mucins and Small Airway Plugging in Cystic Fibrosis","volume":"62","author":"Burgel","year":"2007","journal-title":"Thorax"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1513\/AnnalsATS.201507-455KV","article-title":"Mucus Hyperconcentration as a Unifying Aspect of the Chronic Bronchitic Phenotype","volume":"13","author":"Button","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1126\/science.1223012","article-title":"A Periciliary brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia","volume":"337","author":"Button","year":"2012","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1172\/jci125669","article-title":"IL-1\u03b2 Dominates the Promucin Secretory Cytokine Profile in Cystic Fibrosis","volume":"129","author":"Chen","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.bpj.2016.07.020","article-title":"Particle-Tracking Microrheology Using Micro-optical Coherence Tomography","volume":"111","author":"Chu","year":"2016","journal-title":"Biophysical J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jcf.2018.05.004","article-title":"CFTR Modulator Theratyping: Current Status, Gaps and Future Directions","volume":"18","author":"Clancy","year":"2019","journal-title":"J. Cystic Fibrosis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/nejmoa1807119","article-title":"VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Davies","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e122695","DOI":"10.1172\/jci.insight.122695","article-title":"Effect of Ivacaftor on Mucociliary Clearance and Clinical Outcomes in Cystic Fibrosis Patients with G551D-CFTR","volume":"3","author":"Donaldson","year":"2018","journal-title":"JCI Insight"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1800457","DOI":"10.1183\/13993003.00457-2018","article-title":"The Mucus Bundles Responsible for Airway Cleaning Are Retained in Cystic Fibrosis and by Cholinergic Stimulation","volume":"52","author":"Ermund","year":"2018","journal-title":"Eur. Respir. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2017.08.113","article-title":"The normal Trachea Is Cleaned by MUC5B Mucin Bundles from the Submucosal Glands Coated with the MUC5AC Mucin","volume":"492","author":"Ermund","year":"","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/1440-1681.12744","article-title":"OligoG CF-5\/20 Normalizes Cystic Fibrosis Mucus by Chelating Calcium","volume":"44","author":"Ermund","year":"","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"eaav3488","DOI":"10.1126\/scitranslmed.aav3488","article-title":"Mucus Accumulation in the Lungs Precedes Structural Changes and Infection in Children with Cystic Fibrosis","volume":"11","author":"Esther","year":"2019","journal-title":"Sci. Transl Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e125954","DOI":"10.1172\/jci.insight.125954","article-title":"A Glycopolymer Improves Vascoelasticity and Mucociliary Transport of Abnormal Cystic Fibrosis Mucus","volume":"4","author":"Fernandez-Petty","year":"2019","journal-title":"JCI Insight"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e124863","DOI":"10.1172\/jci.insight.124863","article-title":"Mucus Strands from Submucosal Glands Initiate Mucociliary Transport of Large Particles","volume":"4","author":"Fischer","year":"2019","journal-title":"JCI Insight"},{"key":"B20","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1164\/rccm.200304-505so","article-title":"Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"L1093","DOI":"10.1152\/ajplung.00082.2021","article-title":"Ivacaftor Partially Corrects Airway Inflammation in a Humanized G551D Rat","volume":"320","author":"Green","year":"2021","journal-title":"Am. J. Physiology-Lung Cell Mol. Physiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1084\/jem.20120562","article-title":"Bicarbonate and Functional CFTR Channel Are Required for Proper Mucin Secretion and Link Cystic Fibrosis with its Mucus Phenotype","volume":"209","author":"Gustafsson","year":"2012","journal-title":"J. Exp. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/cid\/ciu944","article-title":"Pseudomonas aeruginosa in Cystic Fibrosis Patients with G551D-CFTR Treated with Ivacaftor","volume":"60","author":"Heltshe","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2101032","DOI":"10.1183\/13993003.01032-2021","article-title":"Static Mucus Impairs Bacterial Clearance and Allows Chronic Infection with Pseudomonas aeruginosa in the Cystic Fibrosis Rat","author":"Henderson","year":"2022","journal-title":"Eur. Respir. J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1172\/jci73469","article-title":"Cystic Fibrosis Airway Secretions Exhibit Mucin Hyperconcentration and Increased Osmotic Pressure","volume":"124","author":"Henderson","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1164\/rccm.200607-1011oc","article-title":"MUC5AC and MUC5B Mucins Increase in Cystic Fibrosis Airway Secretions during Pulmonary Exacerbation","volume":"175","author":"Henke","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e87681","DOI":"10.1371\/journal.pone.0087681","article-title":"A Biophysical Basis for Mucus Solids Concentration as a Candidate Biomarker for Airways Disease","volume":"9","author":"Hill","year":"2014","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1164\/rccm.201609-1954oc","article-title":"Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the Cystic Fibrosis Gene: Genetic Analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"a009589","DOI":"10.1101\/cshperspect.a009589","article-title":"CFTR, Mucins, and Mucus Obstruction in Cystic Fibrosis","volume":"2","author":"Kreda","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e54473","DOI":"10.1371\/journal.pone.0054473","article-title":"Method for Quantitative Study of Airway Functional Microanatomy Using Micro-optical Coherence Tomography","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1165\/rcmb.2013-0499ma","article-title":"An Autoregulatory Mechanism Governing Mucociliary Transport Is Sensitive to Mucus Load","volume":"51","author":"Liu","year":"2014","journal-title":"Am. J. Respir. Cel Mol Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/mi.2017.29","article-title":"Erratum: Contribution of Mucus Concentration and Secreted Mucins Muc5ac and Muc5b to the Pathogenesis of Muco-Obstructive Lung Disease","volume":"10","author":"Livraghi-Butrico","year":"2017","journal-title":"Mucosal Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.chest.2017.11.008","article-title":"Mucins, Mucus, and Goblet Cells","volume":"154","author":"Ma","year":"2018","journal-title":"Chest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/s0092-8674(00)81724-9","article-title":"Evidence for Periciliary Liquid Layer Depletion, Not Abnormal Ion Composition, in the Pathogenesis of Cystic Fibrosis Airways Disease","volume":"95","author":"Matsui","year":"1998","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac117","article-title":"The Rapid Reduction of Infection-Related Visits and Antibiotic Use Among People with Cystic Fibrosis after Starting Elexacaftor-Tezacaftor-Ivacaftor","author":"Miller","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1002\/ppul.24530","article-title":"Mucus, Mucins, and Cystic Fibrosis","volume":"54","author":"Morrison","year":"2019","journal-title":"Pediatr. Pulmonol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2100185","DOI":"10.1183\/13993003.00185-2021","article-title":"Treatment of Cystic Fibrosis Airway Cells with CFTR Modulators Reverses Aberrant Mucus Properties via Hydration","volume":"59","author":"Morrison","year":"2022","journal-title":"Eur. Respir. J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1701926","DOI":"10.1183\/13993003.01926-2017","article-title":"Long-term Benefits of Airway Clearance in Bronchiectasis: a Randomised Placebo-Controlled Trial","volume":"51","author":"Mu\u00f1oz","year":"2018","journal-title":"Eur. Respir. J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.1073\/pnas.1703228114","article-title":"Gel-forming Mucins Form Distinct Morphologic Structures in Airways","volume":"114","author":"Ostedgaard","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1073\/pnas.91.12.5340","article-title":"Bicarbonate Conductance and pH Regulatory Capability of Cystic Fibrosis Transmembrane Conductance Regulator","volume":"91","author":"Poulsen","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/nejmoa1105185","article-title":"A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00010.2005","article-title":"Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and Disease","volume":"86","author":"Rose","year":"2006","journal-title":"Physiol. Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1164\/rccm.201708-1616oc","article-title":"Infection Is Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout Ferrets","volume":"197","author":"Rosen","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1164\/rccm.201404-0703oc","article-title":"Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-Mediated Cystic Fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature12807","article-title":"Muc5b Is Required for Airway Defence","volume":"505","author":"Roy","year":"2014","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/ppul.24341","article-title":"Pathogen Acquisition in Patients with Cystic Fibrosis Receiving Ivacaftor or Lumacaftor\/ivacaftor","volume":"54","author":"Singh","year":"2019","journal-title":"Pediatr. Pulmonol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/bf02789065","article-title":"Identification of Glycoproteins on Nitrocellulose Membranes and Gels","volume":"5","author":"Thornton","year":"1996","journal-title":"Mol. Biotechnol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e91253","DOI":"10.1371\/journal.pone.0091253","article-title":"Characterization of Defects in Ion Transport and Tissue Development in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-knockout Rats","volume":"9","author":"Tuggle","year":"2014","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF Airway Epithelial Cell Function In Vitro by a CFTR Potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B54","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1378\/chest.08-0412","article-title":"Mucins, Mucus, and Sputum","volume":"135","author":"Voynow","year":"2009","journal-title":"Chest"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.884166\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T07:48:19Z","timestamp":1651132099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.884166\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":54,"alternative-id":["10.3389\/fphys.2022.884166"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.884166","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"article-number":"884166"}}